Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
- Status
- COMPLETED
- Phase
- PHASE3
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
- Status
- COMPLETED
- Phase
- PHASE3
ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Use of Topotecan in Patients With Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
- Status
- COMPLETED
- Phase
- PHASE4
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- N/A
Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
- Status
- COMPLETED
- Phase
- PHASE3
Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes
- Status
- COMPLETED
- Phase
- PHASE4